Last Updated: 10/28/16
Development of Clinical Imaging Drugs & Enhancers (DCIDE)
DCIDE is no longer taking applications, as of August 2009. Imaging drug development resources should be requested through the new NExT/CBC program which has its own application and review process. See NCI Experimental Therapeutics Program (NExT). There are 4 review dates per year, instead of the previous DCIDE submission and review process.
Contact regarding programmatic issues:
Barbara Y. Croft, Ph.D.
Cancer Imaging Program, NCI
6130 Executive Blvd., Suite 6000
Bethesda, MD 20892
Telephone: 301-496-9531
Fax: 301-480-3507
E-mail: bc129b@nih.gov
Reports & Publications
Specialized Initiatives
- Phase 2 N01 Program
- Network for Translational Research
- Small Animal Imaging Resource Program (SAIRP)
- Current SAIRP Institutions and Principal Investigators
- University of Michigan
- M D Anderson Cancer Center
- University of Pennsylvania
- Memorial Sloan-Kettering Cancer Center
- Washington University
- Duke University
- Johns Hopkins University
- Massachusetts General Hospital
- Vanderbilt University
- University of California, Los Angeles
- Case Western Reserve University
- University of California at Davis
- University of Texas Southwestern
- ICMIC Institutions
- DCIDE